Par Pharmaceuticals
-
Malvern’s Endo Settles with State of Oklahoma over Its Alleged Role in Opioid Crisis
Two subsidiaries of Malvern-based Endo International have agreed to pay $8.75 million to Oklahoma to resolve the investigation into its alleged role in the state’s…












































